Through the heart and beyond: a review on ranolazine
MONALDI ARCHIVES FOR CHEST DISEASE（2022）
摘要
Ranolazine derives from piperazine and has been approved as a drug for the therapy of chronic stable angina. It acts by selectively inhibiting the late sodium inward current. Moreover, ranolazine has other metabolic features which makes it effective in other diseases as well as coronary artery ones. In this paper I make an updated review of all possible therapeutic roles of ranolazine: through cardiology and beyond.
更多查看译文
关键词
Ranolazine, chronic stable angina, arrhythrnias, diabetes, pulmonary artery hypertension, peripheral arterial disease, non-dystrophic myotonias
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要